Our Brd2 haploinsufficient mouse model provides experimental evidence that reduced expression of Brd2—a gene closely tied to DNA, histones, chromatin structure, transcription, splicing, and possibly DNA methylation—can significantly alter the aging process, provide resistance to tumorigenesis, and delay the development of age-related pathologies in the kidneys. This evidence concerns the gene BRD2 and age.